logo
logo

Brenig Therapeutics Appoints David L. Lucchino As CEO and Tien Dam As CMO

Jul 10, 2025•6 days ago

Position

Chief Medical Officer

Company

Brenig Therapeutics

Tien Dam
SomervilleBiotechnology

Description

Brenig Therapeutics has appointed David L. Lucchino as President and Chief Executive Officer and Tien Dam, M.D. as Chief Medical Officer

Company Information

Company

Brenig Therapeutics

Location

100 Chestnut Street, Suite 300

Somerville, Massachusetts, United States

About

Brenig Therapeutics was co-founded in 2021 by OrbiMed, Torrey Pines, and BGV to design and develop breakthrough medicines for neurodegenerative disorders. Brenig’s mission is to build a robust portfolio of first- and best-in-class therapies targeting a broad spectrum of neurodegenerative diseases, starting with Parkinson’s disease.

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Related People

David hidden

hidden
hidden

Tien hidden

hidden
hidden